{"nct_id":"NCT04784715","title":"Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-04-26","start_date_type":"ACTUAL","primary_completion_date":"2026-07-06","primary_completion_date_type":"ESTIMATED","completion_date":"2029-12-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}